Rhythm Pharmaceuticals Statistics
NASDAQ: RYTMHealthcareBiotechnologyUSD
88.45-2.32 (-2.56%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 88.45 0.00%
Rhythm Pharmaceuticals by the numbers
Rhythm Pharmaceuticals has a market capitalization of $6.09 billion based on 68.85M shares outstanding. With trailing EPS of $-3.12, Rhythm Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.7% below its 50-day average and 10.4% below its 200-day average.
Average daily trading volume is 646.31K shares, or about $57.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RYTM valuation vs. peer median
| Metric | RYTM | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.09B | $5.85B | +4% |
| Avg. volume | 646.31K | 1.16M | -44% |
Peer median across 8 companies: BLTE, IMVT, IOVA, LGND, KOD, CGON, SYRE, PTCT.
Valuation
- Market cap
- $6.09B
- Price / sales (latest FY)
- 32.09
- EPS (TTM)
- $-3.12
- Shares outstanding
- 68.85M
Price and trading
- Previous close
- 90.77
- Open
- 90.77
- Day range
- 88.23 – 91.37
- 52-week range
- 74.50 – 122.20
- 52-week change
- -10.46%
- 50-day moving average
- 104.91
- Beta
- —
- Volume
- 810.74K
- Average volume
- 646.31K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 6.09B
- Forward Pe
- -144.38
- Eps
- -3.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 122.20
- Week52 Low
- 74.50
- Avg Volume
- 646.31K
- Shares Outstanding
- 68.85M
- Ma50
- 104.91
- Ma200
- 98.68
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -27.62%
- Pct From52w Low
- 18.72%